First human safety test for new COPD drug candidate
NCT ID NCT06908642
Summary
This was an early safety study to see how healthy adults tolerate a new tablet called Hemay005, which is being developed for Chronic Obstructive Pulmonary Disease (COPD). Researchers tested different ways of giving the drug to see which method caused fewer side effects. The study involved 468 healthy volunteers and was designed to gather initial safety information before testing in people with the actual disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Second Affiliated Hospital of Wannan Medical College
Wuhu, Anhui, 241000, China
Conditions
Explore the condition pages connected to this study.